Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05152524 · ClinicalTrials.gov registry record · NA
Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever
A NA study of Ischemic Stroke and Neovascularization, sponsored by Rapid Medical.
- Active
- Registry status
- NA
- Development phase
- 168
- Enrollment target
- 20
- Study locations
NCT05152524: Active NA study of Ischemic Stroke and Neovascularization, sponsored by Rapid Medical.
NCT05152524 is a NA study of Ischemic Stroke and Neovascularization that is active but no longer recruiting, run by Rapid Medical. The registered enrollment target is 168 participants, below the 1,461-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (89% lower). The trial reports 20 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05152524, a NA study of Ischemic Stroke and Neovascularization, is active but no longer recruiting, sponsored by Rapid Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of the DISTALS Study is to evaluate the safety and effectiveness of the Tigertriever 13 Revascularization Device in restoring blood flow in the neurovasculature by removing thrombus in patients presenting within 24 hours of onset with an ischemic stroke with disabling neurological deficits due to a primary distal vessel occlusion (DVO), as compared to medical management.
Primary Outcome
\*Successful reperfusion is defined as \>50% reduction in substantial hypoperfusion (Tmax \>4 seconds) volume between baseline and 24 ±6 hours of randomization. \*\*sICH shall be defined as any parenchymal hematoma type 2, remote intracerebral hemorrhage, subarachnoid hemorrhage, or intraventricular hemorrhage that is the predominant cause of ≥4 point NIHSS deterioration at 24 ±6 hours of randomization.
Conditions Studied
Interventions
- DEVICE Tigertriever 13
Study Locations (20)
Other
- CUB Hôpital Erasme - Brussels
- Universitätsklinikum Bonn - Bonn
- Alfreid Krupp - Essen
- Universitätsklinikum Schleswig-Holstein - Kiel
- St. Lukas hospital, Radprax - Solingen
- Orebro University Hospital - Örebro
New York
- University of Buffalo - Buffalo
- NYU Langone Health - New York
- Mount Sinai - New York
- Stony Brook University - Stony Brook
California
- Lakewood Regional Medical Center - Los Angeles
- Los Robles - Thousand Oaks
Michigan
- Corewell Health (Spectrum) - Grand Rapids
- Munson Medical Center - Traverse City
Texas
- Valley Baptist Medical Center - Harlingen
- Texas Stroke Institute - Plano
Georgia
- WellStar Research Institute - Marietta
Illinois
- Advocate Aurora Research Institute, - Chicago
Ohio
- Mercy Health - Toledo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2022-03-25 |
| Est. Completion | 2026-03 |
| Phase | NA |
What the registry record for NCT05152524 still lists
NCT05152524 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 1,461-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Tigertriever 13 is the first listed.
NCT05152524 names 20 study sites across 9 states, led by Other, New York, California.
Frequently Asked Questions
What is clinical trial NCT05152524 about?
NCT05152524 is a clinical study titled "Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever". The objective of the DISTALS Study is to evaluate the safety and effectiveness of the Tigertriever 13 Revascularization Device in restoring blood flow in the neurovasculature by removing thrombus in patients presenting within 24 hours of onset with an ischemic stroke with disabling neurological defi...
What is the current status of trial NCT05152524?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 168 participants. The study started on 2022-03-25. Estimated completion is 2026-03.
What conditions does trial NCT05152524 study?
This clinical trial studies the following conditions: Ischemic Stroke, Neovascularization.
What interventions are being tested in trial NCT05152524?
The interventions under investigation include: Tigertriever 13 (DEVICE).
Who is sponsoring clinical trial NCT05152524?
This trial is sponsored by Rapid Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05152524 being conducted?
This trial has 20 study locations across California, Georgia, Illinois, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05152524's enrollment target sits among peer trials
168 24th of 66 higher than 43 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
StrokeNet Thrombectomy Endovascular Platform
RECRUITING · NA
-
Virtual Reality Based Rehabilitation After Ischemic Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- NCT03536897 · 168 participants
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
- NCT04078230 · 168 participants · NA
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
- NCT04159168 · 168 participants · NA
Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI